Lorlatinib Continuation Study

Clinical trial NCT05144997 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05144997
Sponsor: Pfizer
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Non-Small-Cell Lung Cancer NSCLC

Start date: 2021-12-28
Primary completion: 2026-12-28
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.